Stent Coating to Prevent Restenosis and Subacute Thrombosis

Information

  • Research Project
  • 7753570
  • ApplicationId
    7753570
  • Core Project Number
    R44HL090087
  • Full Project Number
    7R44HL090087-03
  • Serial Number
    90087
  • FOA Number
    PA-06-20
  • Sub Project Id
  • Project Start Date
    8/1/2008 - 15 years ago
  • Project End Date
    7/31/2010 - 13 years ago
  • Program Officer Name
    BALDWIN, TIM
  • Budget Start Date
    3/16/2009 - 15 years ago
  • Budget End Date
    7/31/2009 - 14 years ago
  • Fiscal Year
    2008
  • Support Year
    3
  • Suffix
  • Award Notice Date
    3/9/2009 - 15 years ago
Organizations

Stent Coating to Prevent Restenosis and Subacute Thrombosis

[unreadable] DESCRIPTION (provided by applicant): This fast track SBIR application proposes the refinement and preclinical testing of a coating designed to inhibit restenosis and thrombosis in intravascular stents. The research plan will build on encouraging results from pilot animal studies with coated prototypes. During Phase I, the coating process will be optimized by thoroughly analyzing system variables and verifying coating properties in each step of the coating application. Preliminary biocompatibility testing will be conducted, to identify local effects of the coating on blood and tissue. Upon meeting defined process requirements and biocompatibility requirements, the project will move to Phase II, where the coating process will be implemented in an automated, controlled application apparatus. The coated stents will undergo extensive durability testing. Animal studies are planned that will investigate the activity of the stent in an isolated vessel model. Finally, the stents will be evaluated in a 28-day porcine implant model. The coating is designed as a stand-alone solution to improve stent performance; however, the coating can be combined readily with other coatings or drug-release agents. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    419141
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:419141\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ACCORD BIOMATERIALS, INC.
  • Organization Department
  • Organization DUNS
    622586696
  • Organization City
    ANN ARBOR
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    481038802
  • Organization District
    UNITED STATES